Pelvital

The company's lead product Flyte® has FDA clearance as an at-home intravaginal mechanotherapy device for treating stress urinary incontinence and strengthening pelvic floor muscles. Clinical studies show that 82% of women were continent after six weeks of use. The product delivers surgical-level results without surgery and has been validated by over 20 years of research and development. "Flyte® is FDA cleared and backed by over 20 years of research... Clinically proven to treat stress urinary incontinence. 82% of women were continent in 6 weeks". Strong clinical evidence supports its effectiveness as a first-line conservative treatment for female urinary incontinence.